Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/taylor-francis/making-sense-of-asthma-rKCTF0cAj8
References (29)
-
J. Linden (1994)
Cloned adenosine A3 receptors: pharmacological properties, species differences and receptor functions.Trends in pharmacological sciences, 15 8
-
R. Pauwels, G. Joos, J. Kips, R. Peleman (1993)
Mechanism of adenosine‐induced bronchoconstriction: An animal modelDrug Development Research, 28
-
T. Shirakawa, T. Enomoto, S. Shimazu, J. Hopkin (1996)
The Inverse Association Between Tuberculin Responses and Atopic DisorderScience, 275
-
I. Taylor, K. O'Shaughnessy, R. Fuller, C. Dollery (1991)
Effect of cysteinyl-leukotriene receptor antagonist ICI 204.219 on allergen-induced bronchoconstriction and airway hyperreactivity in atopic subjectsThe Lancet, 337
-
(1995)
Progress in antisense therapeutics, 9
-
A. Driver, C. Kukoly, S. Ali, Syed Mustafa (1993)
Adenosine in bronchoalveolar lavage fluid in asthma.The American review of respiratory disease, 148 1
-
B. Cronstein, Luli, Daguma, Deborah Nichols, Alan, J. Hutchison, Michael, Williams (1990)
The adenosine/neutrophil paradox resolved: human neutrophils possess both A1 and A2 receptors that promote chemotaxis and inhibit O2 generation, respectively.The Journal of clinical investigation, 85 4
-
P. Peachell, L. Lichtenstein, R. Schleimer (1991)
Differential regulation of human basophil and lung mast cell function by adenosine.The Journal of pharmacology and experimental therapeutics, 256 2
-
M. Chiang, H. Chan, Mary Zounes, S. Freier, W. Lima, C. Bennett (1991)
Antisense oligonucleotides inhibit intercellular adhesion molecule 1 expression by two distinct mechanisms.The Journal of biological chemistry, 266 27
-
C. Meade, J. Mierau, I. Leon, H. Ensinger (1996)
In vivo role of the adenosine A3 receptor: N6-2-(4-aminophenyl)ethyladenosine induces bronchospasm in BDE rats by a neurally mediated mechanism involving cells resembling mast cells.The Journal of pharmacology and experimental therapeutics, 279 3
-
A. Driver, C. Kukoly, W. Metzger, Syed Mustafa (1991)
Bronchial challenge with adenosine causes the release of serum neutrophil chemotactic factor in asthma.The American review of respiratory disease, 143 5 Pt 1
-
(1991)
Antisense oligonucleotides inhibit ICAM expression by two dis-tinct mechanisms, 266
-
Eliel Bayever, Patrick Iversen, Michael Bishop, J. Sharp, HEMANT Tewary, M. Arneson, Samuel Pirruccello, Raymond Ruddon, A. Kessinger, Gerald Zon, J. Armitage (1993)
Systemic administration of a phosphorothioate oligonucleotide with a sequence complementary to p53 for acute myelogenous leukemia and myelodysplastic syndrome: initial results of a phase I trial.Antisense research and development, 3 4
-
I. Feoktistov, I. Biaggioni (1995)
Adenosine A2b receptors evoke interleukin-8 secretion in human mast cells. An enprofylline-sensitive mechanism with implications for asthma.The Journal of clinical investigation, 96 4
-
Brian Sproat (1995)
Chemistry and applications of oligonucleotide analogues.Journal of biotechnology, 41 2-3
-
M. Ichinose, N. Nakajima, T. Takahashi, H. Yamauchi, H. Inoue, T. Takishima (1992)
Protection against bradykinin-induced bronchoconstriction in asthmatic patients by neurokinin receptor antagonistThe Lancet, 340
-
E. Lander (1996)
The New Genomics: Global Views of BiologyScience, 274
-
F., A. Acker, H-P., Voss, H., Timmerman (1996)
Chemokines: structure, receptors and functions. A new target for inflammation and asthma therapy?Mediators of Inflammation, 5
-
K. Weiss (1994)
The impact of pharmacologic therapy on the costs of asthma.Allergy proceedings : the official journal of regional and state allergy societies, 15 4
-
C. Wegner, R. Gundel, P. Reilly, N. Haynes, L. Letts, R. Rothlein (1990)
Intercellular adhesion molecule-1 (ICAM-1) in the pathogenesis of asthma.Science, 247 4941
-
Douglas Hay, T. Torphy, B. Undem (1995)
Cysteinyl leukotrienes in asthma: old mediators up to new tricks.Trends in pharmacological sciences, 16 9
-
S. Montefort, S. Holgate, P. Howarth (1993)
Leucocyte-endothelial adhesion molecules and their role in bronchial asthma and allergic rhinitis.The European respiratory journal, 6 7
-
Ronald Korthuis, D Anderson, D. Granger (1994)
Role of neutrophil-endothelial cell adhesion in inflammatory disorders.Journal of critical care, 9 1
-
K. Scanlon, Y. Ohta, H. Ishida, H. Kijima, T. Ohkawa, Anna Kaminski, Jerry Tsai, George Horng, M. Kashani-Sabet (1995)
Oligonucleotide‐mediated modulation of mammalian gene expression 1The FASEB Journal, 9
-
J. Fozard, H. Pfannkuche, H. Schuurman (1996)
Mast cell degranulation following adenosine A3 receptor activation in rats.European journal of pharmacology, 298 3
-
C. Nicholson, R. Challiss, M. Shahid (1991)
Differential modulation of tissue function and therapeutic potential of selective inhibitors of cyclic nucleotide phosphodiesterase isoenzymes.Trends in pharmacological sciences, 12 1
-
A. Northover, B. Northover (1996)
Degranulation of rat omental mast cells by A1 receptor agonists in vitroMediators of Inflammation, 5
-
Mauro Teixeira, R. Gristwood, N. Cooper, P. Hellewell (1997)
Phosphodiesterase (PDE)4 inhibitors: anti-inflammatory drugs of the future?Trends in pharmacological sciences, 18 5
-
P. Gerwins, B. Fredholm (1992)
Stimulation of adenosine A1 receptors and bradykinin receptors, which act via different G proteins, synergistically raises inositol 1,4,5-trisphosphate and intracellular free calcium in DDT1 MF-2 smooth muscle cells.Proceedings of the National Academy of Sciences of the United States of America, 89
- Publisher
- Taylor & Francis
- Copyright
- © 1997 Ashley Publications Ltd.
- ISSN
- 1744-7658
- eISSN
- 1354-3784
- DOI
- 10.1517/13543784.6.9.1143
- Publisher site
- See Article on Publisher Site
Abstract
There is now a high probability that all the genes encoded in the human genome will have been sequenced by the year 2005, resulting in a massive increase in the identification of novel therapeutic targets. The use of new genomic sequence information in conjunction with antisense oligonucleotides is one means by which the gene products playing the most important roles in multifactorial diseases, such as asthma, can be identified. Subsequently, the antisense nucleotides themselves can be used as therapeutic agents, or drugs designed to control the activity of the relevant gene product.
Journal
Expert Opinion on Investigational Drugs – Taylor & Francis
Published: Sep 1, 1997